Rheos Medicines

Recent Finacing

Series A

Recent Raise

$60M

Rheos Medicines applies immunometabolism to modulate immune-cell metabolic pathways, using DNA sequencing, transcriptomic and metabolomic profiling plus patient samples and Immune Cell Encyclopedia to discover T‑cell targets and biomarkers.

Founded 2017

Massachusetts, United States

1-10

Private

rheosrx.com

Highlights

Focus Areas

Biopharma

Biotechnology

Health Care

Recent Investors

Financials

$60M

Total Raised

1

Funding round

1

Investor

Team

Upgrade to view the team

See the team members at Rheos Medicines.